Treated Chronic Hepatitis B Is a Good Prognostic Factor of Diffuse Large B-Cell Lymphoma.

Clinical and molecular hepatology(2023)

引用 1|浏览19
暂无评分
摘要
Our findings indicate that HBV-associated DLBCL patients receiving antiviral treatment have significantly longer TTP and OS after R-CHOP treatment than HBV-unassociated DLBCL patients.
更多
查看译文
关键词
Hepatitis B virus, Non-Hodgkin lymphoma, Rituximab, Chemotherapy, Antiviral agent
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要